Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Anterix (ATEX) Shares Outstanding (Diluted Average) (2020 - 2025)

Anterix's Shares Outstanding (Diluted Average) history spans 6 years, with the latest figure at $18.7 million for Q4 2025.

  • For Q4 2025, Shares Outstanding (Diluted Average) fell 0.54% year-over-year to $18.7 million; the TTM value through Dec 2025 reached $18.7 million, down 0.54%, while the annual FY2025 figure was $18.6 million, 1.08% down from the prior year.
  • Shares Outstanding (Diluted Average) reached $18.7 million in Q4 2025 per ATEX's latest filing, roughly flat from $18.7 million in the prior quarter.
  • In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $19.1 million in Q3 2023 to a low of $17.4 million in Q1 2021.
  • Average Shares Outstanding (Diluted Average) over 5 years is $18.5 million, with a median of $18.7 million recorded in 2025.
  • Peak YoY movement for Shares Outstanding (Diluted Average): rose 6.04% in 2021, then decreased 2.74% in 2024.
  • A 5-year view of Shares Outstanding (Diluted Average) shows it stood at $18.1 million in 2021, then increased by 4.75% to $18.9 million in 2022, then rose by 0.8% to $19.1 million in 2023, then dropped by 1.57% to $18.8 million in 2024, then fell by 0.54% to $18.7 million in 2025.
  • Per Business Quant, the three most recent readings for ATEX's Shares Outstanding (Diluted Average) are $18.7 million (Q4 2025), $18.7 million (Q3 2025), and $18.7 million (Q2 2025).